Dtpa

   
Google
 
Web NewDrugInformation.com

Dtpa


Drug - Dtpa
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Technetium Tc-99m Pentetate Kit
Multiple ingredients are in alphabetical order.

Strength - N/A
The potency of the active ingredient(s), Technetium Tc-99m Pentetate Kit. May repeat for multiple part products.

Applicant - DRAXIMAGE
The firm name holding legal responsibility for Dtpa. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 018511
The FDA assigned number to Dtpa. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Dtpa. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AP
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Dec 29, 1989
The date Dtpa was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Dtpa. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Dtpa is in. Format is RX, OTC, DISCN.

Applicant Full Name - Draximage Inc
The full name of the firm holding legal responsibility for the new application of Dtpa.

Dtpa